174 related articles for article (PubMed ID: 17582001)
41. The human papillomavirus E6 oncogene represses a cell adhesion pathway and disrupts focal adhesion through degradation of TAp63β upon transformation.
Ben Khalifa Y; Teissier S; Tan MK; Phan QT; Daynac M; Wong WQ; Thierry F
PLoS Pathog; 2011 Sep; 7(9):e1002256. PubMed ID: 21980285
[TBL] [Abstract][Full Text] [Related]
42. Silencing oncogene expression in cervical cancer stem-like cells inhibits their cell growth and self-renewal ability.
Gu W; Yeo E; McMillan N; Yu C
Cancer Gene Ther; 2011 Dec; 18(12):897-905. PubMed ID: 21904396
[TBL] [Abstract][Full Text] [Related]
43. Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells.
Yang A; Zhu Z; Kapranov P; McKeon F; Church GM; Gingeras TR; Struhl K
Mol Cell; 2006 Nov; 24(4):593-602. PubMed ID: 17188034
[TBL] [Abstract][Full Text] [Related]
44. Viral interaction: a possible contributing factor in head and neck cancer progression.
Underbrink MP; Hoskins SL; Pou AM; Albrecht T
Acta Otolaryngol; 2008; 128(12):1361-9. PubMed ID: 18607925
[TBL] [Abstract][Full Text] [Related]
45. DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck.
Boldrup L; Coates PJ; Gu X; Nylander K
J Pathol; 2007 Dec; 213(4):384-91. PubMed ID: 17935121
[TBL] [Abstract][Full Text] [Related]
46. c-Myc substitutes for Notch1-CBF1 functions in cooperative transformation with papillomavirus oncogenes.
Subramanyam D; Krishna S
Virology; 2006 Mar; 347(1):191-8. PubMed ID: 16378632
[TBL] [Abstract][Full Text] [Related]
47. Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes.
Caberg JH; Hubert PM; Begon DY; Herfs MF; Roncarati PJ; Boniver JJ; Delvenne PO
Carcinogenesis; 2008 Jul; 29(7):1441-7. PubMed ID: 18566017
[TBL] [Abstract][Full Text] [Related]
48. Apicidin down-regulates human papillomavirus type 16 E6 and E7 transcripts and proteins in SiHa cervical cancer cells.
Luczak MW; Jagodzinski PP
Cancer Lett; 2008 Dec; 272(1):53-60. PubMed ID: 18687520
[TBL] [Abstract][Full Text] [Related]
49. DeltaNp63 isoforms differentially regulate gene expression in squamous cell carcinoma: identification of Cox-2 as a novel p63 target.
Boldrup L; Coates PJ; Gu X; Nylander K
J Pathol; 2009 Aug; 218(4):428-36. PubMed ID: 19391123
[TBL] [Abstract][Full Text] [Related]
50. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway.
Chung MT; Lai HC; Sytwu HK; Yan MD; Shih YL; Chang CC; Yu MH; Liu HS; Chu DW; Lin YW
Gynecol Oncol; 2009 Mar; 112(3):646-53. PubMed ID: 19095296
[TBL] [Abstract][Full Text] [Related]
51. Activation of p53 in cervical cancer cells by human papillomavirus E6 RNA interference is transient, but can be sustained by inhibiting endogenous nuclear export-dependent p53 antagonists.
Koivusalo R; Mialon A; Pitkänen H; Westermarck J; Hietanen S
Cancer Res; 2006 Dec; 66(24):11817-24. PubMed ID: 17178878
[TBL] [Abstract][Full Text] [Related]
52. An in vitro multistep carcinogenesis model for human cervical cancer.
Narisawa-Saito M; Yoshimatsu Y; Ohno S; Yugawa T; Egawa N; Fujita M; Hirohashi S; Kiyono T
Cancer Res; 2008 Jul; 68(14):5699-705. PubMed ID: 18632622
[TBL] [Abstract][Full Text] [Related]
53. Gene expression profiles in HPV-infected head and neck cancer.
Schlecht NF; Burk RD; Adrien L; Dunne A; Kawachi N; Sarta C; Chen Q; Brandwein-Gensler M; Prystowsky MB; Childs G; Smith RV; Belbin TJ
J Pathol; 2007 Nov; 213(3):283-93. PubMed ID: 17893858
[TBL] [Abstract][Full Text] [Related]
54. HPV16E7 mediates HADC chromatin repression and downregulation of MHC class I genes in HPV16 tumorigenic cells through interaction with an MHC class I promoter.
Li H; Ou X; Xiong J; Wang T
Biochem Biophys Res Commun; 2006 Nov; 349(4):1315-21. PubMed ID: 16979588
[TBL] [Abstract][Full Text] [Related]
55. Gene expression profiles reveal an upregulation of E2F and downregulation of interferon targets by HPV18 but no changes between keratinocytes with integrated or episomal viral genomes.
Karstensen B; Poppelreuther S; Bonin M; Walter M; Iftner T; Stubenrauch F
Virology; 2006 Sep; 353(1):200-9. PubMed ID: 16814354
[TBL] [Abstract][Full Text] [Related]
56. Silencing of E6/E7 expression in cervical cancer stem-like cells.
Gu W; McMillan N; Yu C
Methods Mol Biol; 2015; 1249():173-82. PubMed ID: 25348305
[TBL] [Abstract][Full Text] [Related]
57. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.
Vinokurova S; Wentzensen N; Kraus I; Klaes R; Driesch C; Melsheimer P; Kisseljov F; Dürst M; Schneider A; von Knebel Doeberitz M
Cancer Res; 2008 Jan; 68(1):307-13. PubMed ID: 18172324
[TBL] [Abstract][Full Text] [Related]
58. Genetic diversity of human papillomavirus type 16 E6, E7, and L1 genes in Italian women with different grades of cervical lesions.
Cento V; Ciccozzi M; Ronga L; Perno CF; Ciotti M
J Med Virol; 2009 Sep; 81(9):1627-34. PubMed ID: 19626616
[TBL] [Abstract][Full Text] [Related]
59. Differential expression of Rac1 identifies its target genes and its contribution to progression of colorectal cancer.
Gómez del Pulgar T; Bandrés E; Espina C; Valdés-Mora F; Pérez-Palacios R; García-Amigot F; García-Foncillas J; Lacal JC
Int J Biochem Cell Biol; 2007; 39(12):2289-302. PubMed ID: 17766170
[TBL] [Abstract][Full Text] [Related]
60. Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma.
Thierry F
Virology; 2009 Feb; 384(2):375-9. PubMed ID: 19064276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]